ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 184 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,100,101 | -27.1% | 278,528 | -2.0% | 0.01% | -37.5% |
Q4 2022 | $2,879,584 | +5.7% | 284,263 | +3.2% | 0.01% | 0.0% |
Q3 2022 | $2,724,000 | -30.5% | 275,432 | -26.6% | 0.01% | -33.3% |
Q2 2022 | $3,918,000 | -2.0% | 375,062 | -8.6% | 0.01% | +20.0% |
Q1 2022 | $3,998,000 | -40.6% | 410,452 | -12.7% | 0.01% | -33.3% |
Q4 2021 | $6,725,000 | -20.4% | 470,278 | +10.4% | 0.02% | -21.1% |
Q3 2021 | $8,447,000 | +27.7% | 425,878 | +41.8% | 0.02% | +35.7% |
Q2 2021 | $6,614,000 | +6.9% | 300,428 | +66.8% | 0.01% | 0.0% |
Q1 2021 | $6,185,000 | – | 180,128 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |